SGLT-2 Inhibition Beyond Glycemic Control: Exploring the Neuroprotective Properties of Dapagliflozin in Diabetes-Related Neurodegeneration

Authors

  • Abeer Abdelmoneim Said, Salah Mohammed Ibrahim, Wafaa Hassan Ahmed , Somya Elsayed Mohammed Mahdi Author

DOI:

https://doi.org/10.48047/mbw59m89

Keywords:

SGLT-2, Neuroprotective, Dapagliflozin

Abstract

Background: Diabetes mellitus is increasingly recognized not only as a metabolic disorder but also as a condition that predisposes the central nervous system to accelerated aging and neurodegeneration. Chronic hyperglycemia, oxidative stress, neuroinflammation, and mitochondrial  dysfunction collectively contribute 

Downloads

Download data is not yet available.

References

Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591-604.

Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148-160.

Downloads

Published

2024-11-20

How to Cite

SGLT-2 Inhibition Beyond Glycemic Control: Exploring the Neuroprotective Properties of Dapagliflozin in Diabetes-Related Neurodegeneration (Abeer Abdelmoneim Said, Salah Mohammed Ibrahim, Wafaa Hassan Ahmed , Somya Elsayed Mohammed Mahdi , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 6207-6213. https://doi.org/10.48047/mbw59m89